英文論文
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
2023
Tianxia Li, Osamu Kikuchi, Jin Zhou, Yichen Wang, Babita Pokharel, Klavdija Bastl, Prafulla Gokhale, Aine Knott, Yanxi Zhang, John G Doench, Zandra V Ho, Daniel Vt Catenacci, Adam J Bass.
Developing SHP2-based combination therapy for KRAS-amplified cancer.
JCI Insight. 2023 Feb 8;8(3):e152714.
Keiji Nihei, Keiko Minashi, Tomonori Yano, Tadakazu Shimoda, Haruhiko Fukuda, Manabu Muto, JCOG-GIESG Investigators; Junki Mizuaswa, Kohei Takizawa, Ikuo Aoyama, Akiyoshi Ishiyama, Noboru Kawata, Daisuke Kikuchi, Noboru Hanaoka, Ichiro Oda, Yoshinori Morita , Masahiro Tajika, Junko Fujiwara, Yoshinobu Yamamoto, Chikatoshi Katada, Shinichiro Hori , Hisashi Doyama, Tsuneo Oyama, Hiroko Nebiki, Kenji Amagai, Yutaro Kubota, Yasuhiro Inokuchi, Nozomu Kobayashi, Takuto Suzuki, Kingo Hirasawa, Toshihisa Takeuchi, Tomohiro Kadota.
Final analysis of diagnostic endoscopic resection followed by selective chemoradiotherapy for stage I esophageal cancer: JCOG0508
Gastroenterology. 2023 Feb;164(2):296-299.e2.
Tatsuya Ioka,Masashi Kanai,Shogo Kobayashi,Daisuke Sakai,Hidetoshi Eguchi,Hideo Baba,Satoru Seo,Akinobu Taketomi,Tadatoshi Takayama,Hiroki Yamaue,Masahiro Takahashi,Masayuki Sho,Keiko Kamei,Jiro Fujimoto,Masanori Toyoda,Junzo Shimizu,Takuma Goto,Yoshitaro Shindo,Kenichi Yoshimura,Etsuro Hatano,Hiroaki Nagano ,Kansai Hepatobiliary Oncology Group (KHBO)
Randomized phase III study of Gemcitabine, Cisplatin plus S-1 (GCS) versus Gemcitabine, Cisplatin (GC) for Advanced Biliary Tract Cancer (KHBO1401-MITSUBA).
J Hepatobiliary Pancreat Sci. 2023 Jan;30(1):102-110.